---
title: 'The Niche Episode 045 – ThermoFisher + PPD, Trodelvy 2x, DiaSorin + Luminex, Merck, Novartis, and Vicarious'
type: 'episode'
url: 'https://doc.social/episodes/the-niche-episode-045-thermofisher-ppd-trodelvy-2x-diasorin-luminex-merck-novartis-and-vicarious'
show: 'Life Science Today'
show_url: 'https://doc.social/podcasts/life-science-today'
published: '2021-04-19'
audio: 'unavailable — the host retired the file'
---

# The Niche Episode 045 – ThermoFisher + PPD, Trodelvy 2x, DiaSorin + Luminex, Merck, Novartis, and Vicarious

Massive acquisitions in the CRO space, Trodelvy 2x, diagnostic acquisitions, Merck closes COVID vaccine program, Xolair get’s self-injection nod, and tiny robots go for massive SPAC. Sponsorshttps://www.thescopemethod.comStory Referenceshtt…

## Summary

Massive acquisitions in the CRO space, Trodelvy 2x, diagnostic acquisitions, Merck closes COVID vaccine program, Xolair get’s self-injection nod, and tiny robots go for massive SPAC.

**Sponsors
**[https://www.thescopemethod.com](https://www.thescopemethod.com)

**Story References
**[https://tinyurl.com/Niche-045-1](https://tinyurl.com/Niche-045-1)
[https://tinyurl.com/Niche-045-2](https://tinyurl.com/Niche-045-2)
[https://tinyurl.com/Niche-045-3](https://tinyurl.com/Niche-045-3)
[https://tinyurl.com/Niche-045-4](https://tinyurl.com/Niche-045-4)
[https://tinyurl.com/Niche-045-5](https://tinyurl.com/Niche-045-5)
[https://tinyurl.com/Niche-045-6](https://tinyurl.com/Niche-045-6)

**Music by Luke Goodson
**[https://www.soundcloud.com/lukegoodson](https://www.soundcloud.com/lukegoodson)

The Niche Podcast brings you interviews with industry experts top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.